WASHINGTON, DC (Reuters) – President Donald Trump announced plans to impose a 25% or higher tariff on semiconductor and pharmaceutical imports, a move that could significantly impact India’s ...

Novo Nordisk AS is lowering prices of its top-selling WeGovy weight-loss drug in China, as the Danish drugmaker braces for intense competition from local rivals next year when the patent for its ...

ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up to receive our biggest stories as soon as they’re published. These highlights were written by the reporters and editors ...

The tablets are indicated for the treatment of moderate to severe vasomotor symptoms due to menopause. Dultra added, "We are proud to continue our mission of delivering high-quality, affordable ...

Cuban urges FDA fee waiver to boost US generics manufacturing Cost Plus Drugs plans to boost US production if fees are waived FDA charges $360,000 per generic drug approval application Trump promised ...

MISSOURI, USA — Missouri Attorney General Catherine Hanaway is asking a federal court to roll back the U.S. Food and Drug Administration’s recent decision to approve a new generic brand of ...

Teva Pharmaceutical Industries Limited has successfully shifted its strategy, leveraging its generics business to fund growth in specialty medicines, driving a turnaround in performance. TEVA's "Pivot ...

PHOENIX — With flu cases rising overseas in countries like the United Kingdom and a new variant identified in Japan, experts warn that the United States could face an earlier flu season this year.

Novartis has started to feel the squeeze from generics to its top-selling drug, heart therapy Entresto. The erosion was obvious. After MSN Pharmaceuticals opened the floodgates to Entresto generics in ...